| FMRFamide, Molluscan Cardioexcitatory Neuropeptide | C29H42N8O4S | 598.77 | 152165-14-5 | H-Phe-Met-Arg-Phe-NH2 |
| (D-Phe1)-FMRFamide | C29H42N8O4S | 598.77 | 84313-42-8 | H-D-Phe-Met-Arg-Phe-NH2 |
| (D-Met2)-FMRFamide | C29H42N8O4S | 598.77 | 84313-43-9 | H-Phe-D-Met-Arg-Phe-NH2 |
| (D-Phe4)-FMRFamide | C29H42N8O4S | 598.77 | 84413-35-4 | H-Phe-Met-Arg-D-Phe-NH2 |
| (D-Arg3)-FMRFamide | C29H42N8O4S | 598.77 | 84313-44-0 | H-Phe-Met-D-Arg-Phe-NH2 |
| Schisto FLRFamide | C59H86N16O14 | 1243.44 | 121801-61-4 | H-Pro-Asp-Val-Asp-His-Val-Phe-Leu-Arg-Phe-NH2 |
| FMRF-Like Peptide | C44H61N11O10 | 904.04 | 98495-35-3 | Pyr-Asp-Pro-Phe-Leu-Arg-Phe-NH2 |
| FMRF-Like Peptide F1 | C48H75N17O11 | 1066.23 | 113611-68-0 | H-Thr-Asn-Arg-Asn-Phe-Leu-Arg-Phe-NH2 |
| H-Trp-Nle-Arg-Phe-NH2 | C32H45N9O4 | 619.77 | 83903-33-7 | H-Trp-Nle-Arg-Phe-NH2 |
| H-Tyr-Phe-Met-Arg-Phe-NH2 | C38H51N9O6S | 761.95 | 99414-63-8 | H-Tyr-Phe-Met-Arg-Phe-NH2 |
| Neuropeptide AF (human) A-18-F-amide (human), NPAF (human) |
C90H132N26O25 | 1978.20 | 192387-38-5 | H-Ala-Gly-Glu-Gly-Leu-Asn-Ser-Gln-Phe-Trp-Ser-Leu-Ala-Ala-Pro-Gln-Arg-Phe-NH2 |
| Neuropeptide SF (human) | C65H94N18O15 | 1367.57 | 192387-39-6 | H-Ser-Gln-Ala-Phe-Leu-Phe-Gln-Pro-Gln-Arg-Phe-NH2 Trifluoroacetate salt |
| Neuropeptide VF (56-92) (human) NPSF, S-37-F-NH2 |
C195H304N52O51S2 | 4257.01 | H-Ser-Leu-Asn-Phe-Glu-Glu-Leu-Lys-Asp-Trp-Gly-Pro-Lys-Asn-Val-Ile-Lys-Met-Ser-Thr-Pro-Ala-Val-Asn-Lys-Met-Pro-His-Ser-Phe-Ala-Asn-Leu-Pro-Leu-Arg-Phe-NH2 | |
| Neuropeptide VF (124-131) (human) V-8-F-NH2, NPVF |
C45H72N14O10 | 969.16 | 311309-27-0 | H-Val-Pro-Asn-Leu-Pro-Gln-Arg-Phe-NH2 |
| RFRP-3 (rat), Neuropeptide VF Precursor (108-125) amide (rat), RFamide-Related Peptide 2 (rat) | C88H134N26O25S2 | 2020.32 | 420088-80-8 | H-Ala-Asn-Met-Glu-Ala-Gly-Thr-Met-Ser-His-Phe-Pro-Ser-Leu-Pro-Gln-Arg-Phe-NH2 |
| FA-Ala-Arg-OH | C16H23N5O5 | 365.39 | 76079-06-6 | FA-Ala-Arg-OH |
| FA-Ala-Lys-OH | C16H23N3O5 | 337.38 | 76079-03-3 | FA-Ala-Lys-OH |
| FA-Ala-Phe-NH2 | C19H21N3O4 | 355.39 | 29268-00-6 | FA-Ala-Phe-NH2 |
| FA-Arg-Leu-OH | C19H29N5O5 | 407.47 | 158016-08-1 | FA-Arg-Leu-OH |
| FA-Asp-Ala-OH | C14H16N2O7 | 324.29 | 196791-00-1 | FA-Asp-Ala-OH |
| FA-Glu-Glu-OH | C17H20N2O9 | 396.35 | FA-Glu-Glu-OH | |
| FA-Gly-Abu-NH2 | C13H17N3O4 | 279.30 | FA-Gly-Abu-NH2 | |
| FA-Gly-Leu-OH | C15H20N2O5 | 308.33 | 69654-89-3 | FA-Gly-Leu-OH |
| FAGLA | C15H21N3O4 | 307.35 | 26400-33-9 | FA-Gly-Leu-NH2 |
| FA-Gly-Leu-Ala-OH | C18H25N3O6 | 379.42 | 56186-50-6 | FA-Gly-Leu-Ala-OH |
| FA-Gly-Nva-NH2 | C14H19N3O4 | 293.32 | 67607-50-5 | FA-Gly-Nva-NH2 |
| FAGPA | C18H19N3O4 | 341.37 | 26400-34-0 | FA-Gly-Phe-NH2 |
| FA-Gly-Phe-Leu-OH | C24H29N3O6 | 455.51 | FA-Gly-Phe-Leu-OH | |
| FA-Gly-Val-NH2 | C14H19N3O4 | 293.32 | 67607-49-2 | FA-Gly-Val-NH2 |
| FALGPA | C23H32N4O7 | 476.53 | 78832-65-2 | FA-Leu-Gly-Pro-Ala-OH |
| FA-Lys-Ala-OH | C16H23N3O5 | 337.38 | 158016-07-0 | FA-Lys-Ala-OH |
| FA-Lys-Leu-OH | C19H29N3O5 | 379.46 | 158016-09-2 | FA-Lys-Leu-OH |
| FA-Phe-Ala-OH | C19H20N2O5 | 356.38 | 83803-17-2 | FA-Phe-Ala-OH |
| FAPGG | C20H21N3O6 | 399.40 | 64967-39-1 | FA-Phe-Gly-Gly-OH |
| FA-Phe-Lys-OH · HCl | C22H27N3O5 · HCl | 449.93 | FA-Phe-Lys-OH · HCl | |
| FAPP | C25H24N2O5 | 432.48 | 83661-95-4 | FA-Phe-Phe-OH |
| FA-Phe-Phe-Arg-OH | C31H36N6O6 | 588.66 | 86064-76-8 | FA-Phe-Phe-Arg-OH |
| FA-Phe-Val-NH2 | C21H25N3O4 | 383.45 | 93936-27-7 | FA-Phe-Val-NH2 |
| Fibrinogen γ-Chain (117-133) | C84H147N25O27 | 1939.24 | 160927-63-9 | H-Asn-Asn-Gln-Lys-Ile-Val-Asn-Leu-Lys-Glu-Lys-Val-Ala-Gln-Leu-Glu-Ala-OH |
| Fibrinogen γ-Chain (397-411) | C62H99N23O21 | 1502.61 | 80755-86-8 | H-Gly-Gln-Gln-His-His-Leu-Gly-Gly-Ala-Lys-Gln-Ala-Gly-Asp-Val-OH |
